Table 7.
Hypoglycemia Outcomes by treatment phase (ITT population)
| Period 1 | Period 2 | |||||
|---|---|---|---|---|---|---|
| Hypoglycemia | Glar (N = 175) % | NPH (N = 164) % | OR (95%CI) | Glar (N = 152) % | NPH (N = 159) % | OR (95%CI) |
| Threshold <3.1 mmol/L | ||||||
| Overall hypoglycemia | 18.3 | 15.2 | 1.24 (0.70-2.21) | 17.1 | 16.4 | 1.06 (0.58-1.92) |
| Daytime hypoglycemia | 12.6 | 9.8 | 1.33 (0.67-2.63) | 13.2 | 14.5 | 0.90 (0.47-1.71) |
| Nocturnal hypoglycemia | 8.0 | 8.5 | 0.93 (0.43-2.02) | 4.6 | 6.3 | 0.72 (0.27-1.94) |
| Threshold <3.9 mmol/L | ||||||
| Overall hypoglycemia | 25.1 | 22.6 | 1.15 (0.70-1.90) | 25.0 | 23.9 | 1.06 (0.63-1.78) |
| Daytime hypoglycemia | 20.0 | 15.9 | 1.33 (0.76-2.32) | 21.1 | 20.8 | 1.02 (0.59-1.76) |
| Nocturnal hypoglycemia | 9.1 | 12.2 | 0.72 (0.36-1.45) | 5.9 | 9.4 | 0.60 (0.26-1.43) |